NCT06626867
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemia, +17 more
- Locations
-
- Laboratory of Exercise Biochemistry, Department of Sports Sciences, University of Taipei Taipei, Taiwan
Clinical trial condition
Dyslipidemia
Explore clinical trials studying Dyslipidemia. Study availability and eligibility vary by location and protocol.
389 public trials
26 recruiting studies
Dyslipidemia trial results
NCT01414192
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
Not specified
NCT03861533
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Sabah Hosptial Kuwait City, Kuwait
- Centro de Estudios Clínicos de Querétaro (CECLIQ) Querétaro City, Querétaro, Mexico
- King Fahd Military Medical Complex Dhahran, Saudi Arabia
- Cleveland Clinic Abu Dhabi, United Arab Emirates
NCT05384262
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Research Site Glendale, California, United States
- Research Site Brooklyn, Maryland, United States
- Research Site Harrow, United Kingdom
NCT02956590
- Conditions
- Body Weight, Dyslipidemia, Dyslipidemias, +9 more
- Locations
-
- Nemours/Alfred I duPont Hospital for Children Wilmington, Delaware, United States
- Children's National Health System Washington D.C., District of Columbia, United States
- Emory University School of Medicine Atlanta, Georgia, United States
- Riley Hospital for Children at IU Health Indianapolis, Indiana, United States
NCT05184179
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Gyeonggi-do, South Korea
Completed
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
NCT01422421
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +16 more
- Locations
-
- University Hospital, University of the Ryukyus Nishihara, Okinawa, Japan
- Saga University Hospital Saga, Japan
Completed
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
NCT01764633
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Birmingham, Alabama, United States
- Research Site Huntsville, Alabama, United States
- Research Site Mobile, Alabama, United States
Completed
Dyslipidemia and Diabetic Retinopathy
NCT03403283
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- MSD Korea Ltd. Seoul, South Korea